BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 30294921)

  • 21. Evaluation, Diagnosis, and Staging of Cutaneous Lymphoma.
    Olsen EA
    Dermatol Clin; 2015 Oct; 33(4):643-54. PubMed ID: 26433839
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characteristics of primary cutaneous lymphoma according to WHO-EORTC classification in Korea.
    Lee JH; Lee JH; Yoo DS; Kang H; Kim GM; Park HJ; Park CJ; Lee JD; Lee JY; Kim SY
    Clin Exp Dermatol; 2013 Jul; 38(5):457-63. PubMed ID: 23611304
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part II. Prognosis, management, and future directions.
    Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
    J Am Acad Dermatol; 2014 Feb; 70(2):223.e1-17; quiz 240-2. PubMed ID: 24438970
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Second lymphomas and other malignant neoplasms in patients with mycosis fungoides and Sezary syndrome: evidence from population-based and clinical cohorts.
    Huang KP; Weinstock MA; Clarke CA; McMillan A; Hoppe RT; Kim YH
    Arch Dermatol; 2007 Jan; 143(1):45-50. PubMed ID: 17224541
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characteristics of Cutaneous Lymphomas in Korea According to the New WHO-EORTC Classification: Report of a Nationwide Study.
    Han JH; Ko YH; Kang YK; Kim WS; Kim YJ; Kim I; Kim HJ; Min SK; Park CK; Park CS; Shin BK; Yang WI; Oh YH; Lee JS; Lee J; Lee TH; Lee H; Lee HJ; Jeon YK; Cha HJ; Choi YD; Kim CW;
    Korean J Pathol; 2014 Apr; 48(2):126-32. PubMed ID: 24868225
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Myocosis fungoides--an update on a non-mycotic disease.
    Makdisi J; Friedman A
    J Drugs Dermatol; 2013 Jul; 12(7):825-31. PubMed ID: 23884501
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers.
    Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
    J Am Acad Dermatol; 2014 Feb; 70(2):205.e1-16; quiz 221-2. PubMed ID: 24438969
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinicopathologic analysis of cutaneous lymphoma in taiwan: a high frequency of extranodal natural killer/t-cell lymphoma, nasal type, with an extremely poor prognosis.
    Liao JB; Chuang SS; Chen HC; Tseng HH; Wang JS; Hsieh PP
    Arch Pathol Lab Med; 2010 Jul; 134(7):996-1002. PubMed ID: 20586627
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Primary cutaneous B-cell lymphomas - clinicopathological, prognostic and therapeutic characterisation of 54 cases according to the WHO-EORTC classification and the ISCL/EORTC TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sezary syndrome.
    Golling P; Cozzio A; Dummer R; French L; Kempf W
    Leuk Lymphoma; 2008 Jun; 49(6):1094-103. PubMed ID: 18569636
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of the 2008 World Health Organization classification for non-mycosis fungoides, non-Sezary syndrome T/NK-cell lymphomas with primary cutaneous involvement.
    Chang D; Zerbini MCN; Sotto MN; Siqueira SAC; Sanches JA
    J Cutan Pathol; 2015 Dec; 42(12):965-973. PubMed ID: 26268415
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic factors in primary cutaneous lymphomas other than mycosis fungoides and the Sézary syndrome. The French Study Group on Cutaneous Lymphomas.
    Grange F; Hedelin G; Joly P; Beylot-Barry M; D'Incan M; Delaunay M; Vaillant L; Avril MF; Bosq J; Wechsler J; Dalac S; Grosieux C; Franck N; Esteve E; Michel C; Bodemer C; Vergier B; Laroche L; Bagot M
    Blood; 1999 Jun; 93(11):3637-42. PubMed ID: 10339469
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The First Year of the AEVD Primary Cutaneous Lymphoma Registry.
    Peñate Y; Servitje O; Machan S; Fernández-de-Misa R; Estrach MT; Acebo E; Mitxelena J; Ramón MD; Flórez A; Blanes M; Morillo M; Medina S; Bassas J; Zayas A; Espinosa P; Pérez A; Gónzalez-Romero N; Domínguez JD; Muniesa C; López Robles J; Combalia A; Yanguas I; Suh H; Polo-Rodríguez I; Bielsa I; Mateu A; Ferrer B; Descalzo MA; García-Doval I; Ortiz-Romero PL
    Actas Dermosifiliogr (Engl Ed); 2018 Sep; 109(7):610-616. PubMed ID: 29680323
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The new World Health Organization-European Organization for Research and Treatment of Cancer classification for cutaneous lymphomas: a practical marriage of two giants.
    Slater DN
    Br J Dermatol; 2005 Nov; 153(5):874-80. PubMed ID: 16225594
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The applicability of the new WHO-EORTC classification of primary cutaneous lymphomas to a single referral center.
    Khamaysi Z; Ben-Arieh Y; Izhak OB; Epelbaum R; Dann EJ; Bergman R
    Am J Dermatopathol; 2008 Feb; 30(1):37-44. PubMed ID: 18212543
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Primary cutaneous T-cell lymphoma: experience from the Peruvian National Cancer Institute.
    Ruiz R; Morante Z; Mantilla R; Mas L; Casanova L; Gomez HL
    An Bras Dermatol; 2017; 92(5):649-654. PubMed ID: 29166501
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epidemiological changes in cutaneous lymphomas: an analysis of 8593 patients from the French Cutaneous Lymphoma Registry.
    Dobos G; de Masson A; Ram-Wolff C; Beylot-Barry M; Pham-Ledard A; Ortonne N; Ingen-Housz-Oro S; Battistella M; d'Incan M; Rouanet J; Franck F; Vignon-Pennamen MD; Franck N; Carlotti A; Boulinguez S; Lamant L; Petrella T; Dalac S; Joly P; Courville P; Rivet J; Dereure O; Amatore F; Taix S; Grange F; Durlach A; Quéreux G; Josselin N; Moulonguet I; Mortier L; Dubois R; Maubec E; Laroche L; Michel L; Templier I; Barete S; Nardin C; Augereau O; Vergier B; Bagot M;
    Br J Dermatol; 2021 Jun; 184(6):1059-1067. PubMed ID: 33131055
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characteristics of cutaneous lymphomas in Korea.
    Lee MW;
    Clin Exp Dermatol; 2003 Nov; 28(6):639-46. PubMed ID: 14616833
    [TBL] [Abstract][Full Text] [Related]  

  • 38. BCL2 and JUNB abnormalities in primary cutaneous lymphomas.
    Mao X; Orchard G; Lillington DM; Child FJ; Vonderheid EC; Nowell PC; Bagot M; Bensussan A; Russell-Jones R; Young BD; Whittaker SJ
    Br J Dermatol; 2004 Sep; 151(3):546-56. PubMed ID: 15377339
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relative frequency of the different types of cutaneous T cell and natural killer cell lymphomas in Korea based on the proposed WHO classification and the EORTC classification.
    Chang SE; Jee MS; Kim KJ; Choi JH; Sung KJ; Moon KC; Koh JK
    J Dermatol; 2003 Jan; 30(1):42-7. PubMed ID: 12598708
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relative Frequency, Clinical Features, and Survival Outcomes of 395 Patients with Cutaneous Lymphoma in Korea: A Subgroup Analysis per 10-year Period.
    Lee WJ; Lee SH; Moon IJ; Won CH; Chang SE; Choi JH; Park CS; Suh C; Lee MW
    Acta Derm Venereol; 2016 Nov; 96(7):888-893. PubMed ID: 26975334
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.